PT - JOURNAL ARTICLE AU - Cox, Jennifer G. AU - Cole, James H. AU - Kempton, Matthew J. AU - Williams, Steven C. R. AU - de Groot, Marius TI - Volume and Distribution of White Matter Hyperintensities in Rheumatoid Arthritis and Ulcerative Colitis Patients AID - 10.1101/2024.05.30.24308189 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.30.24308189 4099 - http://medrxiv.org/content/early/2024/05/31/2024.05.30.24308189.short 4100 - http://medrxiv.org/content/early/2024/05/31/2024.05.30.24308189.full AB - Brain white matter disruptions have been implicated in contributing to fatigue, brain fog and other central symptoms commonly reported in inflammatory diseases. In this study, we included 252 RA patients with 756 age and sex matched controls and 240 UC patients with 720 age and sex matched controls using the UK Biobank imaging dataset. We looked for differences in total volume of white matter hyperintensities (WMH) between patients compared to controls. Then, using voxelwise analysis, we explored the spatial distribution of these white matter hyperintensities and differences in these between patients and controls and between disease groups.A significantly higher volume of WMH was observed in both the RA (p = 2.0 x 10-8, β = - 0.36, 95% CI = -0.48, -0.23) and UC (p = 0.003, β = -0.19 95% CI = -0.32, -0.07) patients compared to their respective control groups. Voxelwise analysis revealed only a small cluster of RA associated WMH compared to controls.These results indicate an increased risk of white matter hyperintensities in patients with RA and UC. These findings help quantify the effect of inflammation from autoimmune diseases on cerebrovascular health and white matter integrity.Competing Interest StatementJennifer Cox is an industry funded PhD student funded by GlaxoSmithKline and an employee of Johnson & Johnson. GSK and Johnson & Johnson had no role in the design or conduct of the study. Dr. de Groot is a former employee of, and holds shares in GlaxoSmithKline (GSK). GSK had no role in the design or conduct of the study. Dr. Kempton was funded by an MRC Career Development Fellowship (grant MR/J008915/1). Dr. Williams has received research funding from Bionomics, Eli Lilly, the Engineering and Physical Sciences Research Council, GlaxoSmithKline, Johnson & Johnson, Lundbeck, the National Institute of Health Research, Pfizer, Takeda, and Wellcome Trust. The authors acknowledge financial support from the Wellcome Trust and the Engineering and Physical Sciences Research Council for the Kings Medical Engineering Centre and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The other authors report no financial relationships with commercial interests.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data was accessed under UK Biobank application number 40933.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.